Compugen Ltd Cgen Compugen And Bristolmyers Squibb Clinical Collaboration And Equity Investment Conference Call Transcript | Latest News RSS feed

Compugen Ltd Cgen Compugen And Bristolmyers Squibb Clinical Collaboration And Equity Investment Conference Call Transcript - Latest News


Bristol-Myers' Collaboration Deal: Accelerating Potential Creation Value For Compugen Ltd.

On October 11th, Compugen Ltd. (NASDAQ: CGEN) announced a new clinical trial collaboration agreement with Bristol-Myers Squibb ("BMS") (NYSE:BMY). The terms included a $12 million equity ... held a co... read more

Bristol-Myers Squibb and Compugen Announce Clinical Collaboration to Evaluate Therapeutic Regimen in Advanced Solid Tumors

In conjunction with this collaboration, Bristol-Myers Squibb will make a $12 million equity investment ... Call and Webcast Information Compugen management will host a conference call today, Thursday, ... read more

Jefferies Biotech Stocks to Buy With Breakthrough Drug Innovations

Compugen Ltd. (NASDAQ: CGEN ... checkpoint pathways to Bristol-Myers Squibb. The deal is only for the targets, as no drug candidates are in development yet, but Five Prime received a large upfront pay... read more

Looking for another news?


Compugen Ltd Market Cap Score

One of the most famous discoveries of modern finance is that, over the long run, portfolios of small-cap companies tend to outperform portfolios of large-cap companies. There are competing ideas among... read more


Compugen Ltd. (CGEN) Compugen and Bristol-Myers Squibb Clinical Collaboration and Equity Investment Conference Call (Transcript)

Compugen Ltd. (NASDAQ:CGEN) Bristol-Myers Squibb Clinical Collaboration and Equity Investment Conference Call October 11, 2018 8:30 AM ET Executives Elana Holzman - Investor Relations and Corporate Co... read more

Compugen Reports Third Quarter 2018 Results

HOLON, Israel , Nov. 7, 2018 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today reported financial results f... read more

Compugen Reports Third Quarter 2018 Results

HOLON, Israel, Nov. 7, 2018 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer ... Shortly thereafter, we signed a clinical collaboration agreement with Bristol-Myers Squibb, provid... read more

Compugen Reports Third Quarter 2018 Results

HOLON, Israel, Nov. 7, 2018 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer ... Shortly thereafter, we signed a clinical collaboration agreement with Bristol-Myers Squibb, provid... read more

Bristol-Myers Squibb Co. (NYSE:BMY)

Bristol-Myers Squibb Co. (NYSE: BMY) shares dipped on Tuesday after the company reported results from its late-stage lung cancer study. The firm announced that its Phase 3 CheckMate 451 study ... Read ... read more

Compugen Reports Third Quarter 2018 Results

HOLON, Israel, Nov. 7, 2018 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer ... Shortly thereafter, we signed a clinical collaboration agreement with Bristol-Myers Squibb, provid... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us